Clearstead Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $666K | Buy |
9,529
+1,287
| +16% | +$89.9K | 0.01% | 530 |
|
|
2025
Q1 | $606K | Sell |
8,242
-1,420
| -15% | -$104K | 0.01% | 529 |
|
|
2024
Q4 | $633K | Sell |
9,662
-525
| -5% | -$34.4K | 0.01% | 513 |
|
|
2024
Q3 | $794K | Sell |
10,187
-310
| -3% | -$24.2K | 0.01% | 469 |
|
|
2024
Q2 | $819K | Buy |
10,497
+9,167
| +689% | +$715K | 0.01% | 431 |
|
|
2024
Q1 | $103K | Buy |
1,330
+21
| +2% | +$1.63K | 0.01% | 605 |
|
|
2023
Q4 | $88.2K | Sell |
1,309
-1,610
| -55% | -$108K | ﹤0.01% | 612 |
|
|
2023
Q3 | $198K | Buy |
2,919
+1,872
| +179% | +$127K | 0.01% | 573 |
|
|
2023
Q2 | $74.9K | Sell |
1,047
-50
| -5% | -$3.58K | ﹤0.01% | 638 |
|
|
2023
Q1 | $76.1K | Buy |
1,097
+454
| +71% | +$31.5K | 0.01% | 564 |
|
|
2022
Q4 | $43.6K | Hold |
643
| – | – | ﹤0.01% | 645 |
|
|
2022
Q3 | $35K | Sell |
643
-487
| -43% | -$26.5K | ﹤0.01% | 672 |
|
|
2022
Q2 | $75K | Sell |
1,130
-482
| -30% | -$32K | 0.01% | 538 |
|
|
2022
Q1 | $107K | Buy |
1,612
+489
| +44% | +$32.5K | 0.01% | 532 |
|
|
2021
Q4 | $65K | Sell |
1,123
-1,400
| -55% | -$81K | ﹤0.01% | 609 |
|
|
2021
Q3 | $152K | Buy |
2,523
+1,993
| +376% | +$120K | 0.01% | 408 |
|
|
2021
Q2 | $32K | Buy |
530
+480
| +960% | +$29K | ﹤0.01% | 628 |
|
|
2021
Q1 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 949 |
|